Olfactomedin-like protein 3 is a protein that in humans is encoded by the OLFML3 gene.[5] It has been shown to act as a proangiongenic factor in the tumor microenvironment, being released by endothelial cells and pericytes.[6]

This gene has also been associated with pectinate ligament dysplasia and glaucoma in Border Collies.[7]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000116774Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000027848Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Entrez Gene: OLFML3 olfactomedin-like 3".
  6. ^ Miljkovic-Licina M, Hammel P, Garrido-Urbani S, Lee BP, Meguenani M, Chaabane C, et al. (December 2012). "Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage". Molecular Cancer Therapeutics. 11 (12): 2588–2599. doi:10.1158/1535-7163.MCT-12-0245. PMID 23002094.
  7. ^ Oliver JA, Wright H, Massidda PA, Burmeister LM, Mellersh CS (January 2020). "A variant in OLFML3 is associated with pectinate ligament abnormality and primary closed-angle glaucoma in Border Collies from the United Kingdom". Veterinary Ophthalmology. 23 (1): 25–36. doi:10.1111/vop.12680. PMID 31141290. S2CID 169036374.

Further reading